- Home
- SPCB vs CRIS Comparison
SPCB vs CRIS Comparison
Compare SPCB & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPCB
- CRIS
- Stock Information
- Founded
- SPCB 1988
- CRIS 2000
- Country
- SPCB Israel
- CRIS United States
- Employees
- SPCB N/A
- CRIS N/A
- Industry
- SPCB Semiconductors
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SPCB Technology
- CRIS Health Care
- Exchange
- SPCB Nasdaq
- CRIS Nasdaq
- Market Cap
- SPCB 21.1M
- CRIS 21.3M
- IPO Year
- SPCB N/A
- CRIS 2000
- Fundamental
- Price
- SPCB $11.99
- CRIS $2.37
- Analyst Decision
- SPCB Strong Buy
- CRIS Strong Buy
- Analyst Count
- SPCB 1
- CRIS 2
- Target Price
- SPCB $18.00
- CRIS $16.50
- AVG Volume (30 Days)
- SPCB 280.2K
- CRIS 76.2K
- Earning Date
- SPCB 05-14-2025
- CRIS 07-31-2025
- Dividend Yield
- SPCB N/A
- CRIS N/A
- EPS Growth
- SPCB N/A
- CRIS N/A
- EPS
- SPCB 1.89
- CRIS N/A
- Revenue
- SPCB $27,831,000.00
- CRIS $11,202,000.00
- Revenue This Year
- SPCB $2.73
- CRIS $0.93
- Revenue Next Year
- SPCB $22.87
- CRIS $8.10
- P/E Ratio
- SPCB $5.70
- CRIS N/A
- Revenue Growth
- SPCB 2.90
- CRIS 14.17
- 52 Week Low
- SPCB $2.55
- CRIS $1.02
- 52 Week High
- SPCB $18.95
- CRIS $9.72
- Technical
- Relative Strength Index (RSI)
- SPCB 73.82
- CRIS 59.94
- Support Level
- SPCB $8.80
- CRIS $2.23
- Resistance Level
- SPCB $9.90
- CRIS $2.63
- Average True Range (ATR)
- SPCB 0.97
- CRIS 0.18
- MACD
- SPCB 0.30
- CRIS 0.03
- Stochastic Oscillator
- SPCB 92.72
- CRIS 67.09
About SPCB SuperCom Ltd. (Israel)
SuperCom Ltd is an Israel-based provider of traditional and digital identity solutions, providing safety, identification, tracking, and security products to governments and organizations. The company comprises three main Strategic Business Units: e-Gov; IoT and Connectivity, which is the key revenue driver; and Cyber Security. Besides, it also offers a wide range of solutions that include national ID registries, e-passports, biometric visas, automated fingerprint identification systems, digitized driver's licenses, and electronic voter registration and election management using the common platform. The geographical segments of the company include Africa, European countries, South America, the United States, Israel, and the Asia Pacific.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.